Nova Patents
ATE509019T1

Benodiazepine spirohydantoin cgrp receptor antagonists

Abstract

The present invention is directed to compounds that are antagonists of CGRP receptors and that are useful in the treatment or prevention of diseases in which the CGRP is involved, such as headache, migraine and cluster headache. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.

Term

Term ended

Projected expiry passed 10 March 2024, 2.5 years ago.

  1. Priority
  2. Filed
  3. Published
  4. Projected expiry
  5. Today

14 members in 7 offices

This recordMember, by publication datePriority claim

Priority claims2

Priority claims
DocumentOfficeKindDate
45561103United States of AmericaP
2004007715United States of AmericaW

Members14

Family members, oldest first
DocumentOfficeKind
AU2004226018A1AustraliaA1
CA2519515A1CanadaA1
WO2004087649A2World Intellectual Property Organization (WIPO)A2
WO2004087649A3World Intellectual Property Organization (WIPO)A3
EP1606286A2European Patent Office (EPO)A2
US2006189600A1United States of AmericaA1
US7205293B2United States of AmericaB2
JP2007525430AJapanA
EP1606286A4European Patent Office (EPO)A4
AU2004226018B2AustraliaB2
JP4584914B2JapanB2
EP1606286B1European Patent Office (EPO)B1
AT509019TAustriaT
ATE509019T1This recordAustriaT1